Brief: Elanix Biotechnologies announces non-binding letter of intent with Oxford MEStar Ltd
22/11/2016 09:00
Nov 22 (Reuters) - Elanix Biotechnologies AG ELNk.F :
* Elanix Biotechnologies announces non-binding letter of
intent with Oxford MEStar Ltd in regard to setting up a JV to
market GynRepair in China
Source text for Eikon: ID:nEQ9BHShb
Further company coverage: ELNk.F
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 722 0920;))
Recent news on Elanix Biotechnologies AG
See all newsBrief: BaFin Revokes Administrative Fine Order From Dec 9, 2019 For Elanix Biotechnologies
Brief: Elanix Biotechnologies: Vice Chairman Of Supervisory Board Fang Bao Resigns
Brief: BaFin Says Imposed Fines Of 150,000 Euros Against Elanix Biotechnologies
Brief: BaFin Says Imposed Coercive Fines On Elanix Biotechnologies
Brief: BaFin Says Disciplinary Fine Of 250,000 Euros Imposed Against Elanix Biotechnologies